Prescription savings platform GoodRx is collaborating with pharma giant Novo Nordisk to make Ozempic and Wegovy pens ...

We live in a world where $1 billion of prescription medications are left at the pharmacy counter each year, often because ...

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses.

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

Your grip strength serves as a reliable indicator of total muscle power, because it reflects the strength of your entire ...

NewHomeSource reports the top U.S. cities for job growth in 2025. Strong employment markets signal economic stability and ...

CheapInsurance.com reports businesses face rising insurance rates due to increased claims, inflation, and evolving risks, but ...

SmartAsset reports Millennials are buying homes rapidly, with Raleigh-Cary, NC leading at 4.5% homeownership among ages 25-44 ...

SoFi reports that options trading is a high-risk investment strategy involving derivatives that allow investors to speculate ...

Shopify reports millennials prioritize convenience, wellness, and nostalgia in spending, favoring subscriptions and online ...

Moderately bullish activity in Hims and Hers Health (HIMS), with shares down $1.36 near $43.21. Options volume relatively light with 86k contracts ...